Pharmacokinetics and clinical response to single- and multiple-dose sustained-release theophylline compounds in perennial bronchial asthma
- 1 December 1985
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 79 (6) , 54-57
- https://doi.org/10.1016/0002-9343(85)90089-0
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Comparison of morning and evening dosing with a 24-hour sustained-release theophylline, Uniphyl, for nocturnal asthmaThe American Journal of Medicine, 1985
- Study of two controlled-release theophylline preparationsThe American Journal of Medicine, 1985
- Comparison of clinical effects and pharmacokinetics of once daily uniphyl and twice-daily theo-dur in asthmatic patientsThe American Journal of Medicine, 1985
- Serum Profile and Bioavailability of a Controlled-Release Theophylline Formulation for Once-Daily Use: Comparison with a 12-hr PreparationJournal of Asthma, 1984
- A Clinical and Pharmacokinetic Basis for the Selection and Use of Slow Release Theophylline ProductsClinical Pharmacokinetics, 1984
- Long-Term Treatment with Oral Sustained-Release Theophylline.Allergy, 1982
- Effect of Food on the Bioavailability and Pattern of Release of a Sustained‐Release Theophylline TabletThe Journal of Clinical Pharmacology, 1982
- Sustained-release theophylline: A significant advance in the treatment of childhood asthmaThe Journal of Pediatrics, 1982
- SINGLE-DOSE SLOW-RELEASE AMINOPHYLLINE AT NIGHT PREVENTS NOCTURNAL ASTHMAThe Lancet, 1982
- Diurnal variation of asthmaRespiratory Medicine, 1977